Drawing for BLOOMWELL

USPTO serial 97543376

BLOOMWELL

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
ROACH, APRIL K
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with BLOOMWELL?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Hoang-chi Truong

Hoang-chi Truong PATENT LAW WORKS LLP4516 South 700 East, Suite 290SALT LAKE CITY, UT 84107United States

Goods and services

ClassDescriptionStatusFirst use
003Topical lotions, sprays, creams and oils for cosmetic use for the body, skin, hair and nailsACTIVE—
005Dietary and nutritional supplements; vitamins; vitamin supplements; food supplements; herbal supplements; mineral supplementsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Oct 8, 2025MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Oct 8, 2025ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jul 29, 2024EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jul 29, 2024EX2GSOU EXTENSION 2 GRANTED—
Jul 29, 2024EXT2SOU EXTENSION 2 FILED—
Jul 29, 2024EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jan 16, 2024EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jan 12, 2024EX1GSOU EXTENSION 1 GRANTED—
Jan 12, 2024EXT1SOU EXTENSION 1 FILED—
Jan 12, 2024EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Aug 1, 2023NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jun 6, 2023NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jun 6, 2023PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
May 17, 2023NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
May 3, 2023CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
May 3, 2023DOCKASSIGNED TO EXAMINER—
Aug 30, 2022NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Aug 13, 2022NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance